Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-09-06

Clinical Trial Update: Varenicline for Nicotine Dependence Among Those With HIV/AIDS [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating varenicline for nicotine dependence in people with HIV/AIDS has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Varenicline (varenicline)

Snippet

Sponsor: University of Pennsylvania | Conditions: Nicotine Dependence | Phase 3 | Status: COMPLETED | Results posted: 2019-09-06